Skip to main content
RN

Rapid Nexus

Rapid Nexus develops the Hemastyl® wound treatment system, utilizing a patented formula of antimicrobial nanoparticles to effectively treat chronic and non-healing wounds, particularly in diabetic patients. This system addresses the lack of effective therapies for peripheral neuropathy and peri-wound healing, significantly promoting tissue regeneration and reducing infection rates.

Irvine, United StatesFounded 20206700+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Chronic wounds, particularly in diabetic patients, often lack effective treatments that address both infection and nerve regeneration. Existing wound care products may have limited antimicrobial action and fail to promote circulation and tissue growth in the peri-wound area, leading to poor clinical outcomes and potential amputations. Peripheral neuropathy further complicates healing, as nerve damage impairs the body's natural repair mechanisms.

Solution

Rapid Nexus develops the Hemastyl® wound treatment system, a regenerative therapeutic that utilizes a patented formula of antimicrobial nanoparticles to treat chronic and non-healing wounds. The Hemastyl® system is designed to address peripheral neuropathy and promote peri-wound healing, stimulating tissue regeneration and reducing infection rates. The treatment aims to restore local circulation, control infection with bactericidal and fungicidal properties, and stimulate proper tissue growth for effective healing. Hemastyl® is designed for both clinic and home care, offering a comprehensive approach to wound management and amputation prevention.

Target Audience

The primary target audience includes patients with chronic, non-healing wounds, particularly those with diabetic ulcers and peripheral neuropathy, as well as physicians and wound care specialists seeking advanced treatment options.

Features

  • Patented Hemastyl® formula combining unique antimicrobial nanoparticles
  • Bactericidal and fungicidal properties, demonstrating 99.999% effectiveness against Candida Auris and other microbes
  • Promotes local restoration of circulation in the wound area
  • Stimulates proper tissue growth and accelerates the healing process
  • Designed for both clinic and home care applications
  • Addresses nerve damage associated with peripheral neuropathy
This profile is AI-generated and may contain inaccuracies.